8-chloroadenosine-3',5'-cyclic monophosphorothioate has been researched along with h 89 in 2 studies
Studies (8-chloroadenosine-3',5'-cyclic monophosphorothioate) | Trials (8-chloroadenosine-3',5'-cyclic monophosphorothioate) | Recent Studies (post-2010) (8-chloroadenosine-3',5'-cyclic monophosphorothioate) | Studies (h 89) | Trials (h 89) | Recent Studies (post-2010) (h 89) |
---|---|---|---|---|---|
17 | 0 | 1 | 1,619 | 0 | 409 |
Protein | Taxonomy | 8-chloroadenosine-3',5'-cyclic monophosphorothioate (IC50) | h 89 (IC50) |
---|---|---|---|
Rho-associated protein kinase 2 | Homo sapiens (human) | 1.9504 | |
Ribosomal protein S6 kinase alpha-5 | Homo sapiens (human) | 0.12 | |
cAMP-dependent protein kinase catalytic subunit alpha | Bos taurus (cattle) | 0.073 | |
cAMP-dependent protein kinase catalytic subunit alpha | Mus musculus (house mouse) | 0.381 | |
cAMP-dependent protein kinase catalytic subunit alpha | Homo sapiens (human) | 0.6365 | |
cAMP-dependent protein kinase catalytic subunit gamma | Homo sapiens (human) | 0.6365 | |
cAMP-dependent protein kinase catalytic subunit beta | Homo sapiens (human) | 0.6365 | |
Ribosomal protein S6 kinase beta-1 | Homo sapiens (human) | 0.08 | |
RAC-alpha serine/threonine-protein kinase | Homo sapiens (human) | 1.9886 | |
RAC-beta serine/threonine-protein kinase | Homo sapiens (human) | 0.5417 | |
Rho-associated protein kinase 2 | Rattus norvegicus (Norway rat) | 0.27 | |
RAC-gamma serine/threonine-protein kinase | Homo sapiens (human) | 0.3207 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Christie, MJ; Hack, SP; Vaughan, CW | 1 |
Behr, J; Breustedt, J; Fidzinski, P; Maier, N; Schmitz, D; Wozny, C | 1 |
2 other study(ies) available for 8-chloroadenosine-3',5'-cyclic monophosphorothioate and h 89
Article | Year |
---|---|
Modulation of GABA release during morphine withdrawal in midbrain neurons in vitro.
Topics: Action Potentials; Adenosine; Affinity Labels; Animals; Colforsin; Cyclic AMP; Dipyridamole; Dose-Response Relationship, Drug; Drug Interactions; Enkephalins; Enzyme Inhibitors; gamma-Aminobutyric Acid; In Vitro Techniques; Isoquinolines; Male; Mesencephalon; Mice; Mice, Inbred C57BL; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Narcotics; Neural Inhibition; Neurons; Patch-Clamp Techniques; Periaqueductal Gray; Probenecid; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Substance Withdrawal Syndrome; Sulfonamides; Synaptic Transmission; Thioinosine; Time Factors; Uricosuric Agents; Vasodilator Agents; Xanthines | 2003 |
Differential cAMP signaling at hippocampal output synapses.
Topics: Action Potentials; Analysis of Variance; Animals; Calcium; Colforsin; Cyclic AMP; Electric Stimulation; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; GABA Antagonists; Hippocampus; In Vitro Techniques; Isoquinolines; Neurons; Oligopeptides; Patch-Clamp Techniques; Protein Kinase Inhibitors; Pyridazines; Quinoxalines; Rats; Signal Transduction; Sulfonamides; Synapses; Time Factors | 2008 |